Related Experiment Video
Updated: Dec 28, 2025

08:43
Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
8.3K
Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer's Pathophysiology
Xinpeng Shen1, Sisi Ma2, Prashanthi Vemuri3
1Institute for Health Informatics, University of Minnesota, Minneapolis, MN, 55455, USA. shenx582@umn.edu.
Scientific Reports
|February 21, 2020
Summary
Causal Structure Discovery methods accurately identified known relationships in Alzheimer's disease data. Using these algorithms with longitudinal data and prior knowledge maximizes discovery of true causal links.
Area of Science:
- Computational Biology
- Neuroscience
- Data Science
Background:
- Traditional association-based methods struggle to identify causal relationships.
- Causal Structure Discovery (CSD) offers advanced computational approaches.
- Alzheimer's disease (AD) provides a well-defined causal graph for evaluating CSD methods.
Purpose of the Study:
- To assess if CSD methods can uncover known causal links from observational clinical data.
- To provide guidance for accurate causal relationship discovery.
- To evaluate CSD performance using Alzheimer's disease as a model.
Main Methods:
- Evaluated Fast Causal Inference (FCI) and Fast Greedy Equivalence Search (FGES) algorithms.
- Utilized data from the Alzheimer's Disease Neuroimaging Initiative (ADNI).
- Compared CSD results against a literature-derived 'gold standard' causal graph under varying background knowledge scenarios.
Main Results:
- Dedicated CSD methods successfully discovered causal graphs closely matching the gold standard.
- The performance of CSD methods improved with increased background knowledge.
- Structural equation models, not designed for CSD, served as a control.
Conclusions:
- CSD methods are effective for identifying causal relationships in complex diseases like Alzheimer's.
- Optimal results are achieved when CSD algorithms are applied to longitudinal data with substantial prior knowledge.
- This study offers guidance for leveraging CSD in clinical data analysis.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Alzheimer's Disease: Treatment
699
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
699
Dementia
458
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
458
Amyloid Fibrils
11.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.5K
Causality in Epidemiology
1.4K
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
1.4K

